# Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23

> **NCT02020785** · NA · COMPLETED · sponsor: **Geisinger Clinic** · enrollment: 31 (actual)

## Conditions studied

- Albuminuria

## Interventions

- **OTHER:** Higher phosphorus period
- **OTHER:** Lower phosphorus period

## Key facts

- **NCT ID:** NCT02020785
- **Lead sponsor:** Geisinger Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02020785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02020785, "Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02020785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*